Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
SUPERSTRING CAPITAL MANAGEMENT LP (CIK 1931118) reported $140.0M across 33 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: SMMT ($16.9M, 12.09%), IMVT ($8.9M, 6.35%), SVRA ($8.7M, 6.19%), COGT ($8.7M, 6.19%), URGN ($7.0M, 4.98%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | SMMT | SUMMIT THERAPEUTICS INC | $16.9M | 12.09% | 892,873 | New |
| 2 | IMVT | IMMUNOVANT INC | $8.9M | 6.35% | 357,606 | Added |
| 3 | SVRA | SAVARA INC | $8.7M | 6.19% | 1.6M | Added |
| 4 | COGT | COGENT BIOSCIENCES INC | $8.7M | 6.19% | 225,158 | Trimmed |
| 5 | URGN | UROGEN PHARMA LTD | $7.0M | 4.98% | 387,371 | Trimmed |
| 6 | DEFINIUM THERAPEUTICS INC | $6.6M | 4.75% | 351,461 | New | |
| 7 | VIR | VIR BIOTECHNOLOGY INC | $6.5M | 4.68% | 730,548 | New |
| 8 | PCVX | VAXCYTE INC | $6.4M | 4.59% | 110,454 | New |
| 9 | CLDX | CELLDEX THERAPEUTICS INC NEW | $5.7M | 4.08% | 180,048 | Added |
| 10 | SION | SIONNA THERAPEUTICS INC | $5.7M | 4.04% | 141,024 | Trimmed |
| 11 | GMAB | GENMAB A/S | $5.3M | 3.77% | 196,709 | Added |
| 12 | ZLAB | ZAI LAB LTD | $5.2M | 3.71% | 275,818 | Added |
| 13 | VRTX | VERTEX PHARMACEUTICALS INC | $4.9M | 3.51% | 11,010 | New |
| 14 | IQV | IQVIA HLDGS INC | $4.4M | 3.13% | 25,668 | New |
| 15 | MAPLIGHT THERAPEUTICS INC | $3.9M | 2.79% | 192,139 | New | |
| 16 | ARVN | ARVINAS INC | $3.3M | 2.37% | 312,620 | New |
| 17 | ORKA | ORUKA THERAPEUTICS INC | $3.1M | 2.23% | 63,591 | New |
| 18 | UTHR | UNITED THERAPEUTICS CORP DEL | $3.1M | 2.20% | 5,186 | Trimmed |
| 19 | TVTX | TRAVERE THERAPEUTICS INC | $3.1M | 2.18% | 102,754 | Added |
| 20 | TRVI | TREVI THERAPEUTICS INC | $3.0M | 2.14% | 251,566 | Added |
| 21 | ANL | ADLAI NORTYE LTD | $2.9M | 2.05% | 414,852 | New |
| 22 | CABA | CABALETTA BIO INC | $2.9M | 2.05% | 1.1M | Trimmed |
| 23 | PFE | PFIZER INC | $2.1M | 1.48% | 74,000 | New |
| 24 | AXSM | AXSOME THERAPEUTICS INC. | $1.9M | 1.35% | 11,217 | Trimmed |
| 25 | ORIC | ORIC PHARMACEUTICALS INC | $1.5M | 1.04% | 115,234 | Trimmed |
Source: SEC Form 13F filings · as of 2026-03-31